Navigation Links
Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, December 7 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today that Dr. Dalia Cohen, EVP, Global Head of R&D at Rosetta Genomics, will present at RBC Capital Markets 2007 Healthcare conference on Thursday, December 13, at 9:00 am EST at the Westin Hotel in New York.

A live audio webcast of the presentation will be available on the "Investors" section of the company's website, A replay of the presentation will be available for 30 days after the conference.

About Rosetta Genomics

Rosetta Genomics (NASDAQ: ROSG) is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and other indications. For more information please visit:

Contact: Media

Alan Zachary

T: +1(312)-944-6784


Juliane Snowden

T: +1(212)-213-0006

SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
2. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
3. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
4. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
5. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
6. NeoGenomics Announces Results for the 3rd Quarter 2007
7. Webcast Alert: Kaiser Permanente Residency Program Open House
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
10. BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
11. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... Key Housing, a top-rated corporate housing service ... 2015, featured apartment community: Epic. In showcasing this featured apartment community in San Jose, ... Area rental market to efficiently find housing suitable to their needs by showcasing quality ...
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... Manalapan, N.J., has created the COUCH BUDDY. "I conceived of this design due to ... more comfort for couch users. It promotes relaxation and convenience, as well as increases ...
(Date:11/27/2015)... (PRWEB) , ... November 28, 2015 , ... There is ... we outperform our billings from last year? , This question has not been an ... are coming to the retirement age and the younger workforce don’t share the same ...
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, ... in light of the recent terrorist attacks in Paris, other cities are taking extra ... from reaching U.S. soil. Especially around special events that may be high-profile in nature, ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from Hopkinsville, ... prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , The ... medications. In doing so, it could help to prevent potential overdose situations. As ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
Breaking Medicine Technology: